Zou L - Search Results

1

Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma.

Li T, Deng Y, Shi Y, Tian R, Chen Y, Zou L, Kazi JU, Rönnstrand L, Feng B, Chan SO, Chan WY, Sun J, Zhao H. Li T, et al. Among authors: zou l. Oncogene. 2018 Nov;37(47):6180-6194. doi: 10.1038/s41388-018-0397-7. Epub 2018 Jul 16. Oncogene. 2018. PMID: 30013190

2

microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.

He XY, Tan ZL, Mou Q, Liu FJ, Liu S, Yu CW, Zhu J, Lv LY, Zhang J, Wang S, Bao LM, Peng B, Zhao H, Zou L. He XY, et al. Among authors: zou l. Clin Cancer Res. 2017 Jun 1;23(11):2905-2918. doi: 10.1158/1078-0432.CCR-16-1591. Epub 2016 Dec 21. Clin Cancer Res. 2017. PMID: 28003306

3

Epidemiology of 45,616 suspect cases of Hand, Foot and Mouth Disease in Chongqing, China, 2011-2015.

Tao J, He XY, Shi Y, Zhu G, Liu S, Zhang Z, Tang S, Zhang R, Peng B, Liu Z, Tan J, Chen Q, Wang X, Bao L, Zou L, Zhang P. Tao J, et al. Among authors: zou l. Sci Rep. 2017 Apr 19;7:45630. doi: 10.1038/srep45630. Sci Rep. 2017. PMID: 28422128 Free PMC article.

4

ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.

Shu Y, Wang Y, Lv WQ, Peng DY, Li J, Zhang H, Jiang GJ, Yang BJ, Liu S, Zhang J, Chen YH, Tang S, Wan KX, Yuan JT, Guo W, Fu G, Qi XK, Liu ZD, Liu HY, Yang C, Zhang LH, Liu FJ, Yu J, Zhang PH, Qu B, Zhao H, He TC, Zou L. Shu Y, et al. Among authors: zou l. Cancer Res. 2020 Mar 1;80(5):988-998. doi: 10.1158/0008-5472.CAN-19-1471. Epub 2019 Dec 10. Cancer Res. 2020. PMID: 31822496 Free PMC article.

5

Gene signatures associated with genomic aberrations predict prognosis in neuroblastoma.

He X, Qin C, Zhao Y, Zou L, Zhao H, Cheng C. He X, et al. Among authors: zou l. Cancer Commun (Lond). 2020 Mar;40(2-3):105-118. doi: 10.1002/cac2.12016. Cancer Commun (Lond). 2020. PMID: 32237073 Free PMC article.

6

Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.

Weng Z, Lin J, He J, Gao L, Lin S, Tsang LL, Zhang H, He X, Wang G, Yang X, Zhou H, Zhao H, Li G, Zou L, Jiang X. Weng Z, et al. Among authors: zou l. Neuro Oncol. 2022 Jun 1;24(6):872-885. doi: 10.1093/neuonc/noab241. Neuro Oncol. 2022. PMID: 34655293 Free PMC article.

7

Matrine induces autophagy in human neuroblastoma cells via blocking the AKT-mTOR pathway.

Liu N, Yang C, Yang L, Li T, Gong M, Wang H, Zhang J, Zhao H, Zou L, He X. Liu N, et al. Among authors: zou l. Med Oncol. 2022 Aug 16;39(11):167. doi: 10.1007/s12032-022-01762-4. Med Oncol. 2022. PMID: 35972593 Free PMC article.

8

Inhibition of PI3 kinase isoform p110α suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase.

Guo Y, Guo D, Zhang S, Zhang Y, He X, Jiang X, Chan AM, Zou L, Sun J, Zhao H. Guo Y, et al. Among authors: zou l. Cell Biosci. 2022 Dec 30;12(1):210. doi: 10.1186/s13578-022-00946-9. Cell Biosci. 2022. PMID: 36585695 Free PMC article.

9

LncRNA AC142119.1 facilitates the progression of neuroblastoma by epigenetically initiating the transcription of MYCN.

Yang R, Liu N, Li T, Liu F, Zhang J, Zhao H, Zou L, He X. Yang R, et al. Among authors: zou l. J Transl Med. 2023 Sep 23;21(1):659. doi: 10.1186/s12967-023-04535-3. J Transl Med. 2023. PMID: 37741985 Free PMC article.

10

shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity.

Zou L, Zhang P, Luo C, Tu Z. Zou L, et al. Cancer Chemother Pharmacol. 2006 Feb;57(3):328-34. doi: 10.1007/s00280-005-0056-x. Epub 2005 Jul 19. Cancer Chemother Pharmacol. 2006. PMID: 16028098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,682 results

Search Page